IRF3 and pancreatic ductal adenocarcinoma: To extend our findings to cancer-prone chronic inflammation in humans, we examined IL-33 and IRF3 expression in the epithelial cells across 15 matched samples of the normal pancreas, pancreatitis, and pancreatitis-associated pancreatic ductal adenocarcinoma (PDAC).